Christina Bucci‐Rechtweg

3.5k total citations · 1 hit paper
44 papers, 2.2k citations indexed

About

Christina Bucci‐Rechtweg is a scholar working on Orthopedics and Sports Medicine, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Christina Bucci‐Rechtweg has authored 44 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Orthopedics and Sports Medicine, 23 papers in Oncology and 13 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Christina Bucci‐Rechtweg's work include Bone health and treatments (23 papers), Bone health and osteoporosis research (22 papers) and Bone and Joint Diseases (10 papers). Christina Bucci‐Rechtweg is often cited by papers focused on Bone health and treatments (23 papers), Bone health and osteoporosis research (22 papers) and Bone and Joint Diseases (10 papers). Christina Bucci‐Rechtweg collaborates with scholars based in United States, United Kingdom and Switzerland. Christina Bucci‐Rechtweg's co-authors include Steven Boonen, Dennis M. Black, Richard Eastell, Jane A. Cauley, Ping‐Chung Leung, Felicia Cosman, Guoqin Su, Ian R. Reid, Chris Recknor and Trisha F. Hue and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christina Bucci‐Rechtweg

43 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

2011 477 citations Dennis M. Black, Ian R. Reid et al. Journal of Bone and Mineral Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christina Bucci‐Rechtweg United States	20	1.6k	1.4k	588	386	215	44	2.2k
Kelly Krohn United States	23	1.5k 0.9×	852 0.6×	585 1.0×	810 2.1×	321 1.5×	43	2.2k
Mary E. Melton United States	22	1.3k 0.8×	675 0.5×	415 0.7×	539 1.4×	106 0.5×	30	1.7k
Alun Cooper United Kingdom	13	1.1k 0.7×	506 0.4×	339 0.6×	780 2.0×	143 0.7×	21	1.7k
David Macarios United States	18	726 0.4×	559 0.4×	274 0.5×	422 1.1×	60 0.3×	37	1.3k
F. Borgström United Kingdom	14	1.4k 0.9×	541 0.4×	377 0.6×	931 2.4×	171 0.8×	26	1.8k
Susan B. Broy United States	15	1.2k 0.7×	463 0.3×	290 0.5×	578 1.5×	119 0.6×	24	1.5k
Ogo Egbuna United States	18	322 0.2×	371 0.3×	291 0.5×	230 0.6×	72 0.3×	37	1.3k
Johanna H. M. Driessen Netherlands	21	355 0.2×	267 0.2×	331 0.6×	332 0.9×	212 1.0×	86	1.3k
Jacqueline Halton Canada	24	365 0.2×	328 0.2×	190 0.3×	352 0.9×	109 0.5×	56	2.1k
Richard Barron United States	22	218 0.1×	736 0.5×	93 0.2×	184 0.5×	125 0.6×	55	1.3k

Countries citing papers authored by Christina Bucci‐Rechtweg

Since Specialization

Citations

This map shows the geographic impact of Christina Bucci‐Rechtweg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Bucci‐Rechtweg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Bucci‐Rechtweg more than expected).

Fields of papers citing papers by Christina Bucci‐Rechtweg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Bucci‐Rechtweg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Bucci‐Rechtweg. The network helps show where Christina Bucci‐Rechtweg may publish in the future.

Co-authorship network of co-authors of Christina Bucci‐Rechtweg

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Bucci‐Rechtweg. A scholar is included among the top collaborators of Christina Bucci‐Rechtweg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Bucci‐Rechtweg. Christina Bucci‐Rechtweg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Toulmonde, Maud, Christina Bucci‐Rechtweg, Gianluca Rossato, et al.. (2023). Growing wiser with age: Results from the ACCELERATE Fostering Age Inclusive Research Group clinical trial survey.. Journal of Clinical Oncology. 41(16_suppl). e13596–e13596. 1 indexed citations

Sewell, Catherine, Leslie Meltzer Henry, Christina Bucci‐Rechtweg, et al.. (2022). Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials. American Journal of Obstetrics and Gynecology. 227(6). 805–811. 32 indexed citations

David, Anna L., Homa K. Ahmadzia, Richard Ashcroft, et al.. (2022). Improving Development of Drug Treatments for Pregnant Women and the Fetus. Therapeutic Innovation & Regulatory Science. 56(6). 976–990. 11 indexed citations

Gamalo, Margaret, Christina Bucci‐Rechtweg, Robert M. Nelson, et al.. (2022). Extrapolation as a Default Strategy in Pediatric Drug Development. Therapeutic Innovation & Regulatory Science. 56(6). 883–894. 10 indexed citations

Ariagno, Ronald L., Judy L. Aschner, Sandra Sundquist Beauman, et al.. (2021). The culture of research communication in neonatal intensive care units: key stakeholder perspectives. Journal of Perinatology. 41(12). 2826–2833. 7 indexed citations

Johnson, Tamara, Leyla Şahin, Christina Bucci‐Rechtweg, et al.. (2017). Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary. Clinical Pharmacology & Therapeutics. 101(6). 736–744. 63 indexed citations

Barrett, Jeffrey S., Raafat Bishai, Christina Bucci‐Rechtweg, et al.. (2017). Challenges and Opportunities in the Development of Medical Therapies for Pediatric Populations and the Role of Extrapolation. Clinical Pharmacology & Therapeutics. 103(3). 419–433. 26 indexed citations

Offringa, Martin, Jonathan M. Davis, M. Turner, et al.. (2015). Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014. Therapeutic Innovation & Regulatory Science. 49(5). 623–631. 7 indexed citations

Reid, Ian R., Dennis M. Black, Richard Eastell, et al.. (2013). Reduction in the Risk of Clinical Fractures After a Single Dose of Zoledronic Acid 5 Milligrams. The Journal of Clinical Endocrinology & Metabolism. 98(2). 557–563. 76 indexed citations

10.

Devogelaer, Jean‐Pierre, Philip N. Sambrook, Donald Reid, et al.. (2013). Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids. Lara D. Veeken. 52(6). 1058–1069. 13 indexed citations

11.

Boonen, Steven, Guoqin Su, Eric Orwoll, et al.. (2011). Antifracture efficacy and safety of once-yearly Zoledronic acid 5mg in men with osteoporosis: a prospective, randomized, controlled trial. Open Repository and Bibliography (University of Liège). 1 indexed citations

12.

Black, Dennis M., Ian R. Reid, Steven Boonen, et al.. (2011). The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). Journal of Bone and Mineral Research. 27(2). 243–254. 477 indexed citations breakdown →

13.

Roux, Christian, David M. Reid, J. P. Devogelaer, et al.. (2011). Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Osteoporosis International. 23(3). 1083–1090. 23 indexed citations

14.

Cauley, Jane A., Steven R. Cummings, Felicia Cosman, et al.. (2011). Fracture risk reduction with zoledronic acid by predicted fracture risk score. Bone. 48. S93–S93. 1 indexed citations

15.

Colón‐Emeric, Cathleen, Kenneth W. Lyles, Guoqin Su, et al.. (2011). Clinical Risk Factors for Recurrent Fracture after Hip Fracture: A Prospective Study. Calcified Tissue International. 88(5). 425–431. 9 indexed citations

16.

Orwoll, Eric, Paul D. Miller, Jonathan D. Adachi, et al.. (2010). Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study. Journal of Bone and Mineral Research. 25(10). 2239–2250. 129 indexed citations

17.

Black, Dennis M., Michael P. Kelly, Harry K. Genant, et al.. (2010). Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. New England Journal of Medicine. 362(19). 1761–1771. 373 indexed citations

18.

Colón‐Emeric, Cathleen, Lars Nordsletten, Nancy M. Major, et al.. (2010). Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporosis International. 22(8). 2329–2336. 69 indexed citations

19.

Cosman, Felicia, E.F. Eriksen, Christopher Recknor, et al.. (2010). Effects of once-yearly zoledronic acid 5mg in combination with teriparatide (PTH) on postmenopausal women with osteoporosis. Bone. 47. S55–S56. 2 indexed citations

20.

McClung, Michael R., Paul D. Miller, Chris Recknor, et al.. (2009). Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass. Obstetrics and Gynecology. 114(5). 999–1007. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact